1. Home
  2. KFY vs MLTX Comparison

KFY vs MLTX Comparison

Compare KFY & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KFY
  • MLTX
  • Stock Information
  • Founded
  • KFY 1969
  • MLTX 2021
  • Country
  • KFY United States
  • MLTX Switzerland
  • Employees
  • KFY N/A
  • MLTX N/A
  • Industry
  • KFY Diversified Commercial Services
  • MLTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • KFY Consumer Discretionary
  • MLTX Health Care
  • Exchange
  • KFY Nasdaq
  • MLTX Nasdaq
  • Market Cap
  • KFY 3.5B
  • MLTX 3.4B
  • IPO Year
  • KFY 1999
  • MLTX N/A
  • Fundamental
  • Price
  • KFY $67.60
  • MLTX $52.67
  • Analyst Decision
  • KFY Buy
  • MLTX Strong Buy
  • Analyst Count
  • KFY 4
  • MLTX 9
  • Target Price
  • KFY $77.00
  • MLTX $77.43
  • AVG Volume (30 Days)
  • KFY 452.8K
  • MLTX 187.6K
  • Earning Date
  • KFY 12-05-2024
  • MLTX 11-07-2024
  • Dividend Yield
  • KFY 2.15%
  • MLTX N/A
  • EPS Growth
  • KFY 137.12
  • MLTX N/A
  • EPS
  • KFY 4.67
  • MLTX N/A
  • Revenue
  • KFY $2,708,790,000.00
  • MLTX N/A
  • Revenue This Year
  • KFY N/A
  • MLTX N/A
  • Revenue Next Year
  • KFY $5.40
  • MLTX N/A
  • P/E Ratio
  • KFY $14.33
  • MLTX N/A
  • Revenue Growth
  • KFY N/A
  • MLTX N/A
  • 52 Week Low
  • KFY $54.77
  • MLTX $37.55
  • 52 Week High
  • KFY $80.64
  • MLTX $64.98
  • Technical
  • Relative Strength Index (RSI)
  • KFY 32.22
  • MLTX 50.68
  • Support Level
  • KFY $65.51
  • MLTX $50.21
  • Resistance Level
  • KFY $70.85
  • MLTX $54.10
  • Average True Range (ATR)
  • KFY 1.87
  • MLTX 2.61
  • MACD
  • KFY -0.63
  • MLTX -0.28
  • Stochastic Oscillator
  • KFY 22.02
  • MLTX 30.56

About KFY Korn Ferry

Korn Ferry is a United States-based firm engaged in organizational consulting and management recruitment that helps clients fill mid- to high-level management positions. The company's segment includes Consulting; Digital; Executive Search; Professional Search & Interim; and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The consulting segment aligns organizational structure, culture, performance, development, and people to drive sustainable growth by addressing four fundamental organizational and talent needs. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

Share on Social Networks: